United States · FDA National Drug Code directory
Brevital Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42023-105_6efcbde7-9a3d-4d12-93ea-793a9e72725a
- Product NDC
- 42023-105
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- methohexital sodium
- Labeler
- Par Health USA, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20071101
- Source listing expiry
- 20271231
Source-listed ingredients
- METHOHEXITAL SODIUM — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (42023-105-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL · 42023-105-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →